These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 16505053

  • 1. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB.
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [Abstract] [Full Text] [Related]

  • 2. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP, Kompella UB.
    Eur J Pharmacol; 2005 Mar 28; 511(2-3):191-8. PubMed ID: 15792788
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
    Ayalasomayajula SP, Kompella UB.
    Eur J Pharmacol; 2003 Jan 05; 458(3):283-9. PubMed ID: 12504784
    [Abstract] [Full Text] [Related]

  • 4. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.
    Kompella UB, Bandi N, Ayalasomayajula SP.
    Invest Ophthalmol Vis Sci; 2003 Mar 05; 44(3):1192-201. PubMed ID: 12601049
    [Abstract] [Full Text] [Related]

  • 5. Effect of diabetes on transscleral delivery of celecoxib.
    Cheruvu NP, Amrite AC, Kompella UB.
    Pharm Res; 2009 Feb 05; 26(2):404-14. PubMed ID: 18987961
    [Abstract] [Full Text] [Related]

  • 6. Effect of eye pigmentation on transscleral drug delivery.
    Cheruvu NP, Amrite AC, Kompella UB.
    Invest Ophthalmol Vis Sci; 2008 Jan 05; 49(1):333-41. PubMed ID: 18172110
    [Abstract] [Full Text] [Related]

  • 7. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration.
    Ayalasomayajula SP, Kompella UB.
    Pharm Res; 2004 Oct 05; 21(10):1797-804. PubMed ID: 15553225
    [Abstract] [Full Text] [Related]

  • 8. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP.
    Invest Ophthalmol Vis Sci; 2001 Sep 05; 42(10):2408-13. PubMed ID: 11527957
    [Abstract] [Full Text] [Related]

  • 9. Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
    Dhanda DS, Tyagi P, Mirvish SS, Kompella UB.
    J Control Release; 2013 Jun 28; 168(3):239-50. PubMed ID: 23562638
    [Abstract] [Full Text] [Related]

  • 10. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS, Tyagi P, Edelhauser HF, Kompella UB.
    Int J Pharm; 2012 Sep 15; 434(1-2):140-7. PubMed ID: 22633904
    [Abstract] [Full Text] [Related]

  • 11. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP, Lee FL, Kuo PC, Wu AC, Cheng HC, Chen SL, Tung TH, Tsao YP.
    Mol Vis; 2007 Jan 31; 13():133-41. PubMed ID: 17293777
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas.
    Ayalasomayajula SP, Amrite AC, Kompella UB.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):275-8. PubMed ID: 15364005
    [Abstract] [Full Text] [Related]

  • 13. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S, Yang Q, Hou M, Han Q, Zhang H, Wang J, Qi C, Bo Q, Ru Y, Yang W, Gu Z, Wei R, Cao Y, Li X, Zhang Y.
    Cell Physiol Biochem; 2018 Sep 13; 45(2):505-522. PubMed ID: 29402864
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW.
    Invest Ophthalmol Vis Sci; 2010 Feb 13; 51(2):1044-51. PubMed ID: 19710406
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR, Suh W.
    Arch Pharm Res; 2017 Feb 13; 40(2):197-203. PubMed ID: 27988882
    [Abstract] [Full Text] [Related]

  • 16. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X, Zhu Q, Xia X, Zhang S, Gu Q, Luo D.
    Curr Eye Res; 2004 Apr 13; 28(4):251-6. PubMed ID: 15259294
    [Abstract] [Full Text] [Related]

  • 17. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
    Amrite AC, Edelhauser HF, Singh SR, Kompella UB.
    Mol Vis; 2008 Jan 29; 14():150-60. PubMed ID: 18334929
    [Abstract] [Full Text] [Related]

  • 18. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R, Chiavaroli C, Garay RP, Hannaert P.
    Eur J Pharmacol; 2004 Jul 14; 495(2-3):217-24. PubMed ID: 15249173
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J, Morikawa S, Shimizu K, Ezaki T, Yasuda Y, Hori S.
    Exp Eye Res; 2013 Jan 14; 106():64-73. PubMed ID: 23178551
    [Abstract] [Full Text] [Related]

  • 20. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
    Exp Eye Res; 2012 May 14; 98():37-43. PubMed ID: 22449442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.